Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for May 17th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, May 17th:

Westlake Chemical Partners LP (WLKP - Free Report) : This ethylene production facilities and related assets operator, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.

Westlake Chemical has a PEG ratio of 0.66, compared with 1.00 for the industry. The company possesses a Growth Score of B.

iRobot Corporation (IRBT - Free Report) : This robots manufacturer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.8% over the last 60 days.

iRobot has a PEG ratio of 1.11, compared with 1.87 for the industry. The company possesses a Growth Score of A.

Woodward, Inc. (WWD - Free Report) : This manufacturer of control solutions for the aerospace and industrial markets, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3% over the last 60 days.

Woodward has a PEG ratio of 1.82, compared with 2.06 for the industry. The company possesses a Growth Score of B.

Woodward, Inc. PEG Ratio (TTM)

Woodward, Inc. PEG Ratio (TTM)

Woodward, Inc. peg-ratio-ttm | Woodward, Inc. Quote

Cabot Oil & Gas Corporation (COG - Free Report) : This independent oil and gas company, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.

Cabot Oil & Gas has a PEG ratio of 0.38, compared with 0.71 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in